MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome
MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome
MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome